Breaking News

The structural failures that make quitting smoking so hard

September 28, 2024
Smoking_cessation_series_2-2048x1152Eros Dervishi for STAT

Millions of Americans want to quit smoking. Critics say drugmakers and the FDA are failing them

Drugmakers have largely written off the expensive and time-consuming work of investigating new ways to treat nicotine addiction, for fear that the eventual product wouldn't be profitable enough to warrant the effort. Read more.

By Nicholas Florko



image1-4-1600x900 (1)
Courtesy Akeso

Exclusive: The little-known Chinese biotech whose cancer drug beat Keytruda has global ambitions

Recent headlines about a potent new immunotherapy have mostly focused on the U.S. company helping to develop it. Less attention has been paid to Akeso, a Chinese biotech that had kept a low profile until its drug bested Merck's mega-blockbuster Keytruda in a late-stage lung cancer trial. Read more.

By Jonathan Wosen


Jeff Pachoud/AFP via Getty Images

Can MRIs ensure prostate cancer screening does more good than harm?

A new study showed that using MRI scans can reduce unnecessary diagnosis and treatment of screen-detected prostate cancer by more than half. Experts believe this research could be the "last piece of the puzzle" for rethinking prostate cancer screening guidelines. Read more.

By Angus Chen

In case you missed it...


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Weekend Reads? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2024, All Rights Reserved.

No comments